These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3485161)

  • 1. Hydrolytic model for cefotaxime and ceftriaxone resistance in beta-lactamase-derepressed Enterobacter cloacae.
    Livermore DM; Riddle SJ; Davy KW
    J Infect Dis; 1986 Mar; 153(3):619-22. PubMed ID: 3485161
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of cephalosporinase of enterobacteria by ceftriaxone].
    Péchinot A; Duez JM; Nordmann P; Kazmierczak A; Labia R
    Pathol Biol (Paris); 1986 May; 34(5):399-403. PubMed ID: 3534712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of beta-lactamase hydrolysis and outer membrane permeability to ceftriaxone resistance in Enterobacter cloacae.
    Marchou B; Bellido F; Charnas R; Lucain C; Pechère JC
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1589-95. PubMed ID: 3501699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the kinetic interaction between ceftriaxone and some beta-lactamases.
    Amicosante G; Maccarrone M; Franceschini N; Oliva B; Segatore B; Oratore A
    Drugs Exp Clin Res; 1988; 14(1):25-30. PubMed ID: 3260552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model system to demonstrate that beta-lactamase-associated antibiotic trapping could be a potential means of resistance.
    Gutmann L; Williamson R
    J Infect Dis; 1983 Aug; 148(2):316-21. PubMed ID: 6310004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of enhanced cefotaxime resistance in Enterobacter spp.
    Hopkins JM; Towner KJ; Slack RC; Harper PB; Simpson IN
    J Antimicrob Chemother; 1987 Oct; 20(4):489-96. PubMed ID: 3500163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four French hospitals.
    Legrand P; Fournier G; Buré A; Jarlier V; Nicolas MH; Decré D; Duval J; Philippon A
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):527-9. PubMed ID: 2504594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity of cefotiam on beta-lactamase-producing bacteria in an in-vitro model.
    Wiedemann B; Seeberg AH
    J Antimicrob Chemother; 1984 Feb; 13(2):111-9. PubMed ID: 6323374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-lactamase activity and cross-resistance to different cephalosporins of in vitro selected cefamandole-resistant variants of Enterobacter cloacae.
    Vuye A
    J Pharm Belg; 1982; 37(4):267-72. PubMed ID: 6982969
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of inhibition of chromosomal beta-lactamases by third-generation cephalosporins.
    Charnas RL; Then RL
    Rev Infect Dis; 1988; 10(4):752-60. PubMed ID: 3142012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of beta-lactam multiresistant variants of gram-negative bacilli in the presence of cefotaxime.
    Svarva PL; Lyng RV; Maeland JA
    Scand J Infect Dis; 1985; 17(4):387-91. PubMed ID: 3911375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal beta-lactamase expression and antibiotic resistance in Enterobacter cloacae.
    Yang YJ; Livermore DM; Williams RJ
    J Med Microbiol; 1988 Mar; 25(3):227-33. PubMed ID: 3258037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams.
    Vu H; Nikaido H
    Antimicrob Agents Chemother; 1985 Mar; 27(3):393-8. PubMed ID: 3873215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced in-vitro bactericidal activity of amikacin combined with latamoxef, cefotaxime and aztreonam against multi-resistant Enterobacter cloacae.
    Giamarellou H; Evagelopoulou V; Lelekis M
    J Antimicrob Chemother; 1989 Apr; 23(4):537-45. PubMed ID: 2787316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of disk approximation and agar dilution induction tests for demonstration of in vitro antagonism of cefotaxime by cefoxitin in Enterobacter species.
    Chandler SW; Nolte FS
    Eur J Clin Microbiol; 1987 Aug; 6(4):476-8. PubMed ID: 3499317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefpirome (HR 810): lack of selection of beta-lactamase overproducing variants.
    Cullmann W; Dick W
    J Antibiot (Tokyo); 1985 Jul; 38(7):912-9. PubMed ID: 3875601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.
    Aronoff SC; Shlaes DM
    J Infect Dis; 1987 May; 155(5):936-41. PubMed ID: 3104483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.
    Seeberg AH; Tolxdorff-Neutzling RM; Wiedemann B
    Antimicrob Agents Chemother; 1983 Jun; 23(6):918-25. PubMed ID: 6351733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of resistance types in Enterobacter cloacae 1977 and 1985.
    Søgaard P; Togsverd E; Mansa B
    Acta Pathol Microbiol Immunol Scand B; 1987 Oct; 95(5):297-302. PubMed ID: 3499749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of beta-lactamase induction on susceptibility to cephalosporins in Enterobacter cloacae and Serratia marcescens.
    Okonogi K; Sugiura A; Kuno M; Higashide E; Kondo M; Imada A
    J Antimicrob Chemother; 1985 Jul; 16(1):31-42. PubMed ID: 3900023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.